Skip to content

Directly observed therapy shown to be of value for some patients

Lower CD4 cell count in Ethiopians doesn't mean shorter survival

HIV-positive patients coinfected with HCV up to 80% more likely to die even with HIV treatment

UK study finds patients coinfected with HIV/HCV more likely to progress to AIDS

Large European study finds HIV/HCV coinfected patients do not have an increased risk of HIV disease progression

Why Brazil’s HIV/AIDS programme is a model for the rest of the world

Routine lactate monitoring warranted only in those at risk, concludes Swiss study

Mother-to-child transmission may be more common with subtype D than A

Flagship mother-to-child transmission prevention programme in Lusaka only 30% effective

Antiretroviral therapy reduces HIV transmission through breast milk

Gay men who use methamphetamine three times more likely to get HIV, says US study

Co-trimoxazole in Malawi: risks may outweigh benefits

South Africa: Erratic infant formula supply puts PMTCT at risk

Panacos announces results of first agent in new drug class

US men's study finds cumulative NRTI use, but not PIs or NNRTIs, associated with insulin resistance

Hepatitis C co-infection blunts response to antiretroviral therapy

Death rate falls in drug users after introduction of effective HIV treatment

NNRTIs have a greater risk of resistance than PIs when used in regimens after treatment break